Loading…
TLRY
Tilray Brands, Inc.
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 88688T209
$2.93+0.34%Price as of Oct 23, 00:39 UTC · updated once a day, after the close
At a glance
Tilray Brands, Inc. (TLRY) is listed on NASDAQ and classified in Drug Manufacturers - Specialty & Generic, part of the Healthcare sector. It is headquartered in Leamington, Canada and has 3,595 employees. The company is worth $433.02M. Revenue was $915.45M in fiscal 2026, up 11.5% from the year before. It reported a net loss of $121.4M. The share price is 81.3% below its 52-week high of $15.70. 5 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Ken Griffin (Citadel Advisors), at $3.9M. In that quarter, 2 of them opened or added to the position. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $433.02M
- P/E
- —
- Forward P/E
- 20.6x
- P/B
- 0.3x
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$1.41
- ROE
- -9.38%
- Profit margin
- -17.05%
- Revenue growth
- +22.70%
- Beta
- 1.92
- 52-week high
- $15.70
- 52-week low
- $2.81
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -97.0% over 5Y.
today you would have $29.51▼ -97.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 9 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $3.04 | $9.03 | $13.30 | $23.00 | $26.90 | $70.30 | $82.60 | $171.30 | $705.40 | |
| P/S | 2.3x | 0.5x | 1.2x | 1.4x | 2.6x | 2.3x | 6.2x | 7.0x | — | — |
| P/B | 0.5x | 0.3x | 0.7x | 0.3x |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ALLOAllogene Therapeutics, Inc. | $1.25 | — | 1.0x | 0.00% | -42.39% | $431.86M |
| SPRYARS Pharmaceuticals, Inc. | $4.32 | — | 34.3x | 0.00% | -210.35% | $429.61M |
| EPRXEupraxia Pharmaceuticals Inc | $6.62 | — | 4.3x | 0.00% | -66.70% | $437.41M |
| PRTAProthena Corp Public Ltd Co |
About the company
- 3,595
- Leamington, Canada